Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Initial experience with anti-CD19 CAR-T cell therapy in patients with Relapsed/Refractory diffuse large B-cell lymphoma in a brazilian cancer center

Bianca Cal, Breno Aires de Souza, Julia Ferreira Campos, Julia Aith Baltazar, Gioavanna Alves Peruzini, Matheus de Lima Garcia, Luciana Magalhães Brandão, Nina Maia Santana, Julia Curi Amarante, Arthur Gomes Oliveira Braga, Ana Cordeiro, Vanessa Bovolenta, Thais Rodrigues da Cunha Fischer, Talita Maira Bueno da Silveira, Marjorie Batista, Marina de Mattos Nascimento, Jayr Schmidt Filho

Blood (2025) 146 (Supplement 1): 7237.

https://doi.org/10.1182/blood-2025-7237

Published: 2025

Journal Articles

Outcomes of HLA-matched unrelated versus haploidentical hematopoietic cell transplantation in acute leukemia: A multicenter observational study in Brazil facilitated by the CIBMTR

Blood (2025) 146 (Supplement 1): 5981.

https://doi.org/10.1182/blood-2025-5981

Published: 2025

Journal Articles

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Blood (2025) 146 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2025-2524

Published: 2025

Journal Articles

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 288.

https://doi.org/10.1182/blood-2025-288

Published: 2025

Journal Articles

Real-world data on anti-BCMA CAR-T in Brazil: A single-center retrospective case series

Bianca Cal, Humberto Villefort, Vanessa Bovolenta, Ana Cordeiro, Marjorie Batista, Marta Lemos, Jayr Schmidt Filho

Blood (2025) 146 (Supplement 1): 7523.

https://doi.org/10.1182/blood-2025-7523

Published: 2025

Journal Articles

Endemic infections following CAR19-T-cell therapy: Real-life evidence in single-center in Brazil

Vanessa Bovolenta, Anita Cortez, Bianca Cal, Ana Cordeiro, Marina de Mattos Nascimento, Arthur Gomes Oliveira Braga, Humberto Villefort, Jayr Schmidt Filho, Marjorie Batista

Blood (2025) 146 (Supplement 1): 7681.

https://doi.org/10.1182/blood-2025-7681

Published: 2025

Journal Articles

First-line venetoclax-based regimens versus chemoimmunotherapy in chronic lymphocytic leukemia: A real-world analysis from the brazilian CLL registry

Samir Nabhan, Gabriel Cunha, Verena Pfister, Leila Perobelli, Erika Oshiro, Rodrigo Santucci, Milton Aranha, Talita Silveira, Jayr Schmidt Filho, Danielle De Farias, Cristiana Solza, Valeria Buccheri, Thiago Carneiro, Vera Figueiredo, Maura Colturato, Abel Costa, Fernanda Marques, Caio Cesar Justino, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 7413.

https://doi.org/10.1182/blood-2025-7413

Published: 2025

Journal Articles

Modifications in risk classification of acute myeloid leukemias undergoing less intensive chemotherapy comparing the 2022 and 2024 stratifications of the european leukemianet and their impact on treatment decision, response rates and outcomes of a brazilian cancer center.

Luciana Magalhães Brandão, Julia Aith Baltazar, Nina Maia Santana, Breno Aires de Souza, Matheus de Lima Garcia, Gioavanna Alves Peruzini, Bianca Cal, Julia Ferreira Campos, Arthur Gomes Oliveira Braga, Julia Curi Amarante, Ana Cordeiro, Vanessa Bovolenta, Marina de Mattos Nascimento, Jayr Schmidt Filho

Blood (2025) 146 (Supplement 1): 6943.

https://doi.org/10.1182/blood-2025-6943

Published: 2025

Journal Articles

Disparities in diagnosis and management of myelodysplastic syndromes in a brazilian cancer center: A comparison between public and private healthcare systems.

Arthur Gomes Oliveira Braga, Julia Curi Amarante, Humberto Villefort, Sahlua Miguel Volc, Marina de Mattos Nascimento, Jayr Schmidt Filho

Blood (2025) 146 (Supplement 1): 2654.

https://doi.org/10.1182/blood-2025-2654

Published: 2025

Journal Articles

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Gabriel Cunha, Pedro Perez, Fernanda Marques, Verena Pfister, Rodrigo Santucci, Milton Aranha, Danielle De Farias, Talita Silveira, Jayr Schmidt Filho, Valeria Buccheri, Roberto Silva, Leila Perobelli, Glaciano Ribeiro, Maura Colturato, Nelson Hamerschlak, Pedro Fernandes, Fernanda Santos Azevedo, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2025-3909

Published: 2025

Journal Articles

Feasibility of anti-BCMA CAR-T therapy in a middle-income country

Humberto Villefort, Andrea Acencio, Julia Curi Amarante, Vanessa Bovolenta, Ana Cordeiro, Bianca Cal, Jayr Schmidt Filho

Blood (2025) 146 (Supplement 1): 4016.

https://doi.org/10.1182/blood-2025-4016

Published: 2025

Journal Articles

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Blood (2024) 144 (Supplement 1): 3774.

https://doi.org/10.1182/blood-2024-209038

Published: 2024

Journal Articles

Allogenic Transplant in Mycosis Fungoides: Never or Never Too Late?Brazilian Single Center Experience

Ana Luisa Oliveira, Thais Fischer, Julia Aith Balthazar, Lais Lie Abrantes, Jayr Schmidt Filho, Talita Silveira

Blood (2024) 144 (Supplement 1): 6424.

https://doi.org/10.1182/blood-2024-212143

Published: 2024

Journal Articles

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Verena Pfister, Fernanda de Morais Marques, Vinicius Campos de Molla, Flavia Parra, Mihoko Yamamoto, Rodrigo Santucci, Milton A. F. Aranha, Valeria Buccheri, Glaciano Ribeiro, Vera Figueiredo, Nelson Hamerschlak, Abel Costa Neto, Jayr Schmidt Filho, Talita Silveira, Adriana Scheliga, Matheus Vescovi Goncalves, Leila Perobelli, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 2348.

https://doi.org/10.1182/blood-2024-210706

Published: 2024

Journal Articles

Localized Nodal Diffuse Large B Cell Lymphoma: Is Radiotherapy Needed?

Anita C. Cortez, Arthur Gomes Oliveira G.O. Braga, Thais R.C. Fischer, Jayr Schmidt-Filho, Talita M.B. Silveira

Blood (2022) 140 (Supplement 1): 12145.

https://doi.org/10.1182/blood-2022-170548

Published: 2022

Journal Articles

The Downgraded Lymphoma: Case Series of High-Grade Lymphoma Relapsing As a Low-Grade after Treatment

Arthur G.O. Braga, João Victor A. Castro, Anita C. Cortez, Humberto V.S. Chaves, Marina M. Nascimento, Fernanda L.M. Gallo, Thais R.C. Fischer, Jayr Schmidt-Filho, Felipe D'A. Costa, Talita M.B. Silveira

Blood (2022) 140 (Supplement 1): 12098–12099.

https://doi.org/10.1182/blood-2022-164850

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Initial experience with anti-CD19 CAR-T cell therapy in patients with Relapsed/Refractory diffuse large B-cell lymphoma in a brazilian cancer center

Outcomes of HLA-matched unrelated versus haploidentical hematopoietic cell transplantation in acute leukemia: A multicenter observational study in Brazil facilitated by the CIBMTR

Impact of TBI, donor age, and transplant era on outcomes of allogeneic transplantation in acute lymphoblastic leukemia: Evidence from 748 patients in Latin America

Healthcare inequities in Latin America outweigh the benefits of pediatric regimens in adult acute lymphoblastic leukemia

Real-world data on anti-BCMA CAR-T in Brazil: A single-center retrospective case series

Endemic infections following CAR19-T-cell therapy: Real-life evidence in single-center in Brazil

First-line venetoclax-based regimens versus chemoimmunotherapy in chronic lymphocytic leukemia: A real-world analysis from the brazilian CLL registry

Modifications in risk classification of acute myeloid leukemias undergoing less intensive chemotherapy comparing the 2022 and 2024 stratifications of the european leukemianet and their impact on treatment decision, response rates and outcomes of a brazilian cancer center.

Disparities in diagnosis and management of myelodysplastic syndromes in a brazilian cancer center: A comparison between public and private healthcare systems.

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Feasibility of anti-BCMA CAR-T therapy in a middle-income country

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Allogenic Transplant in Mycosis Fungoides: Never or Never Too Late?Brazilian Single Center Experience

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Localized Nodal Diffuse Large B Cell Lymphoma: Is Radiotherapy Needed?

The Downgraded Lymphoma: Case Series of High-Grade Lymphoma Relapsing As a Low-Grade after Treatment

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only